$ATRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Atara Biotherapeutics, Inc.. Get notifications about new insider transactions in Atara Biotherapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.01 | 3,900 | 152,139 | 342,138 | 346 K to 342.1 K (-1.13 %) |
Feb 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.52 | 3,900 | 150,228 | 346,038 | 349.9 K to 346 K (-1.11 %) |
Feb 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 38.49 | 20,324 | 782,271 | 334,618 | 354.9 K to 334.6 K (-5.73 %) |
Feb 11 2019 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 38.55 | 13,975 | 538,736 | 272,718 | 286.7 K to 272.7 K (-4.87 %) |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Option Exercise | A | 38.47 | 34,125 | 1,312,789 | 34,125 | |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Grant | A | 0.00 | 17,063 | 0 | 64,063 | 47 K to 64.1 K (+36.30 %) |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 24,683 | 0 | 375,611 | 400.3 K to 375.6 K (-6.17 %) |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Berger Dietmar | Global Head of R&D | Option Exercise | A | 38.47 | 50,000 | 1,923,500 | 50,000 | |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Berger Dietmar | Global Head of R&D | Grant | A | 0.00 | 25,000 | 0 | 75,000 | 50 K to 75 K (+50.00 %) |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Kim Mina | Senior VP & General ... | Option Exercise | A | 38.47 | 34,125 | 1,312,789 | 34,125 | |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Kim Mina | Senior VP & General ... | Grant | A | 0.00 | 17,063 | 0 | 60,063 | 43 K to 60.1 K (+39.68 %) |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | A | 38.47 | 35,000 | 1,346,450 | 35,000 | |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Grant | A | 0.00 | 17,500 | 0 | 47,146 | 64.6 K to 47.1 K (-27.07 %) |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Payment of Exercise | F | 38.47 | 2,212 | 85,096 | 29,646 | 31.9 K to 29.6 K (-6.94 %) |
Feb 01 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 69,500 | |
Feb 01 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 38.44 | 500 | 19,220 | 31,858 | 32.4 K to 31.9 K (-1.55 %) |
Feb 01 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 37.80 | 1,000 | 37,800 | 32,358 | 33.4 K to 32.4 K (-3.00 %) |
Feb 01 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.82 | 430 | 15,403 | 296,452 | 296.9 K to 296.5 K (-0.14 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.98 | 3,470 | 121,381 | 296,882 | 300.4 K to 296.9 K (-1.16 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.58 | 100 | 3,658 | 300,352 | 300.5 K to 300.4 K (-0.03 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.59 | 800 | 28,472 | 300,452 | 301.3 K to 300.5 K (-0.27 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.84 | 3,000 | 104,520 | 301,252 | 304.3 K to 301.3 K (-0.99 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.50 | 2,200 | 75,900 | 4,078 | 6.3 K to 4.1 K (-35.04 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.93 | 1,700 | 57,681 | 6,278 | 8 K to 6.3 K (-21.31 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.16 | 2,000 | 70,320 | 7,978 | 10 K to 8 K (-20.04 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.51 | 1,900 | 65,569 | 9,978 | 11.9 K to 10 K (-16.00 %) |
Jan 02 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 71,000 | |
Jan 02 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 35.00 | 1,500 | 52,500 | 31,858 | 33.4 K to 31.9 K (-4.50 %) |
Jan 02 2019 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.40 | 500 | 17,700 | 11,878 | 12.4 K to 11.9 K (-4.04 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.60 | 3,400 | 117,640 | 12,378 | 15.8 K to 12.4 K (-21.55 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.19 | 653 | 22,326 | 15,778 | 16.4 K to 15.8 K (-3.97 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 32.82 | 3,247 | 106,567 | 16,431 | 19.7 K to 16.4 K (-16.50 %) |
Dec 13 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.75 | 3,900 | 166,725 | 19,678 | 23.6 K to 19.7 K (-16.54 %) |
Dec 13 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.56 | 3,900 | 165,984 | 23,578 | 27.5 K to 23.6 K (-14.19 %) |
Dec 03 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 72,500 | |
Dec 03 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 42.54 | 127 | 5,403 | 31,858 | 32 K to 31.9 K (-0.40 %) |
Dec 03 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 41.97 | 400 | 16,788 | 31,985 | 32.4 K to 32 K (-1.24 %) |
Dec 03 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 40.61 | 973 | 39,514 | 32,385 | 33.4 K to 32.4 K (-2.92 %) |
Dec 03 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.26 | 2,500 | 105,650 | 27,478 | 30 K to 27.5 K (-8.34 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.13 | 1,400 | 57,582 | 29,978 | 31.4 K to 30 K (-4.46 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.54 | 1,200 | 47,448 | 31,378 | 32.6 K to 31.4 K (-3.68 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.65 | 2,700 | 104,355 | 32,578 | 35.3 K to 32.6 K (-7.65 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.49 | 2,800 | 99,372 | 35,278 | 38.1 K to 35.3 K (-7.35 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.67 | 1,100 | 38,137 | 38,078 | 39.2 K to 38.1 K (-2.81 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.51 | 600 | 20,706 | 39,178 | 39.8 K to 39.2 K (-1.51 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.89 | 3,300 | 111,837 | 39,778 | 43.1 K to 39.8 K (-7.66 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 33.81 | 775 | 26,203 | 285,580 | 286.4 K to 285.6 K (-0.27 %) |
Nov 08 2018 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Sell | S | 36.35 | 10,000 | 363,500 | 7,590 | 17.6 K to 7.6 K (-56.85 %) |
Nov 07 2018 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 36.38 | 21,374 | 777,586 | 88,818 | 110.2 K to 88.8 K (-19.40 %) |
Nov 07 2018 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 36.38 | 21,374 | 777,586 | 88,818 | 110.2 K to 88.8 K (-19.40 %) |
Nov 02 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 74,000 | |
Nov 02 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 35.00 | 1,500 | 52,500 | 31,858 | 33.4 K to 31.9 K (-4.50 %) |
Nov 02 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.18 | 800 | 28,144 | 43,078 | 43.9 K to 43.1 K (-1.82 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.39 | 1,700 | 58,463 | 43,878 | 45.6 K to 43.9 K (-3.73 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.17 | 1,400 | 46,438 | 45,578 | 47 K to 45.6 K (-2.98 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.26 | 795 | 27,237 | 46,978 | 47.8 K to 47 K (-1.66 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.66 | 3,105 | 104,514 | 47,773 | 50.9 K to 47.8 K (-6.10 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.00 | 100 | 4,100 | 50,878 | 51 K to 50.9 K (-0.20 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.25 | 1,900 | 76,475 | 50,978 | 52.9 K to 51 K (-3.59 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.58 | 1,900 | 75,202 | 52,878 | 54.8 K to 52.9 K (-3.47 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.34 | 1,300 | 53,742 | 54,778 | 56.1 K to 54.8 K (-2.32 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.09 | 2,600 | 104,234 | 56,078 | 58.7 K to 56.1 K (-4.43 %) |
Oct 02 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 75,500 | |
Oct 02 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 41.99 | 400 | 16,796 | 31,858 | 32.3 K to 31.9 K (-1.24 %) |
Oct 02 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 41.02 | 1,100 | 45,122 | 32,258 | 33.4 K to 32.3 K (-3.30 %) |
Oct 02 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |
Sep 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 43.08 | 13,500 | 581,580 | 286,355 | 299.9 K to 286.4 K (-4.50 %) |
Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 41.23 | 3,500 | 144,305 | 299,855 | 303.4 K to 299.9 K (-1.15 %) |
Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.26 | 10,000 | 402,600 | 303,355 | 313.4 K to 303.4 K (-3.19 %) |
Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.53 | 3,931 | 159,323 | 313,355 | 317.3 K to 313.4 K (-1.24 %) |
Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 39.74 | 14,069 | 559,102 | 317,286 | 331.4 K to 317.3 K (-4.25 %) |
Sep 25 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 39.85 | 79,328 | 3,161,221 | 733,285 | 812.6 K to 733.3 K (-9.76 %) |
Sep 25 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 39.85 | 22,158 | 882,996 | 243,966 | 266.1 K to 244 K (-8.33 %) |
Sep 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.99 | 3,900 | 155,961 | 58,678 | 62.6 K to 58.7 K (-6.23 %) |
Sep 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.62 | 3,900 | 154,518 | 62,578 | 66.5 K to 62.6 K (-5.87 %) |
Sep 12 2018 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Option Exercise | A | 41.05 | 16,500 | 677,325 | 16,500 | |
Sep 11 2018 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Buy | P | 36.80 | 2,000 | 73,600 | 47,000 | 45 K to 47 K (+4.44 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.23 | 1,827 | 73,500 | 66,478 | 68.3 K to 66.5 K (-2.67 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.74 | 2,073 | 82,381 | 68,305 | 70.4 K to 68.3 K (-2.95 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.42 | 1,120 | 44,150 | 70,378 | 71.5 K to 70.4 K (-1.57 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.45 | 2,780 | 106,891 | 71,498 | 74.3 K to 71.5 K (-3.74 %) |
Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 77,000 | |
Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 40.04 | 498 | 19,940 | 31,858 | 32.4 K to 31.9 K (-1.54 %) |
Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 39.16 | 1,002 | 39,238 | 32,356 | 33.4 K to 32.4 K (-3.00 %) |
Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |
Aug 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.69 | 3,900 | 143,091 | 74,278 | 78.2 K to 74.3 K (-4.99 %) |
Aug 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.04 | 3,900 | 140,556 | 78,178 | 82.1 K to 78.2 K (-4.75 %) |
Aug 16 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 35.90 | 382 | 13,714 | 266,124 | 266.5 K to 266.1 K (-0.14 %) |
Aug 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 37.54 | 775 | 29,094 | 331,355 | 332.1 K to 331.4 K (-0.23 %) |
Aug 07 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.75 | 300 | 11,325 | 82,078 | 82.4 K to 82.1 K (-0.36 %) |
Aug 07 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.35 | 3,600 | 134,460 | 82,378 | 86 K to 82.4 K (-4.19 %) |
Aug 07 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.48 | 3,900 | 146,172 | 85,978 | 89.9 K to 86 K (-4.34 %) |
Aug 01 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 78,500 | |
Aug 01 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 40.40 | 100 | 4,040 | 31,858 | 32 K to 31.9 K (-0.31 %) |
Aug 01 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 39.05 | 300 | 11,715 | 31,958 | 32.3 K to 32 K (-0.93 %) |
Aug 01 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 37.65 | 100 | 3,765 | 32,258 | 32.4 K to 32.3 K (-0.31 %) |
Aug 01 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 37.09 | 1,000 | 37,090 | 32,358 | 33.4 K to 32.4 K (-3.00 %) |
Aug 01 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |
Jul 31 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 10,000 | 204,000 | 80,000 | |
Jul 31 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 36.37 | 1,900 | 69,103 | 31,858 | 33.8 K to 31.9 K (-5.63 %) |
Jul 31 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 35.64 | 8,100 | 288,684 | 33,758 | 41.9 K to 33.8 K (-19.35 %) |
Jul 31 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 10,000 | 204,000 | 41,858 | 31.9 K to 41.9 K (+31.39 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.53 | 1,700 | 63,801 | 89,878 | 91.6 K to 89.9 K (-1.86 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.55 | 2,200 | 80,410 | 91,578 | 93.8 K to 91.6 K (-2.35 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.45 | 100 | 3,945 | 93,778 | 93.9 K to 93.8 K (-0.11 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.02 | 3,800 | 148,276 | 93,878 | 97.7 K to 93.9 K (-3.89 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.54 | 6,100 | 247,294 | 97,678 | 103.8 K to 97.7 K (-5.88 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.93 | 22,300 | 890,439 | 103,778 | 126.1 K to 103.8 K (-17.69 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.63 | 2,141 | 86,989 | 126,078 | 128.2 K to 126.1 K (-1.67 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.88 | 27,859 | 1,111,017 | 128,219 | 156.1 K to 128.2 K (-17.85 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.40 | 500 | 19,700 | 156,078 | 156.6 K to 156.1 K (-0.32 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.57 | 1,500 | 56,355 | 156,578 | 158.1 K to 156.6 K (-0.95 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.79 | 1,700 | 69,343 | 158,078 | 159.8 K to 158.1 K (-1.06 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.01 | 2,700 | 108,027 | 159,778 | 162.5 K to 159.8 K (-1.66 %) |
Jun 19 2018 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 45.29 | 400 | 18,116 | 110,192 | 110.6 K to 110.2 K (-0.36 %) |
Jun 19 2018 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 44.68 | 2,100 | 93,828 | 110,592 | 112.7 K to 110.6 K (-1.86 %) |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Grant | A | 0.00 | 1,500 | 0 | 15,189 | 13.7 K to 15.2 K (+10.96 %) |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Grant | A | 0.00 | 1,500 | 0 | 8,500 | 7 K to 8.5 K (+21.43 %) |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 1,500 | 0 | 8,500 | 7 K to 8.5 K (+21.43 %) |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Grant | A | 0.00 | 1,500 | 0 | 112,692 | 111.2 K to 112.7 K (+1.35 %) |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Grant | A | 0.00 | 1,500 | 0 | 21,854 | 20.4 K to 21.9 K (+7.37 %) |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 1,500 | 0 | 14,000 | 12.5 K to 14 K (+12.00 %) |
Jun 07 2018 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Option Exercise | A | 42.30 | 75,000 | 3,172,500 | 75,000 | |
Jun 07 2018 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 45,000 | 0 to 45 K |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 48.59 | 1,000 | 48,590 | 162,478 | 163.5 K to 162.5 K (-0.61 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 47.69 | 1,500 | 71,535 | 163,478 | 165 K to 163.5 K (-0.91 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.53 | 1,900 | 88,407 | 164,978 | 166.9 K to 165 K (-1.14 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 50.27 | 1,200 | 60,324 | 166,878 | 168.1 K to 166.9 K (-0.71 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 49.51 | 3,200 | 158,432 | 168,078 | 171.3 K to 168.1 K (-1.87 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 50.88 | 4,400 | 223,872 | 171,278 | 175.7 K to 171.3 K (-2.50 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 53.64 | 900 | 48,276 | 175,678 | 176.6 K to 175.7 K (-0.51 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 52.83 | 2,000 | 105,660 | 176,578 | 178.6 K to 176.6 K (-1.12 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 51.67 | 1,500 | 77,505 | 178,578 | 180.1 K to 178.6 K (-0.83 %) |
May 21 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 50.03 | 25,860 | 1,293,776 | 107,972 | 133.8 K to 108 K (-19.32 %) |
May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 11.00 | 25,000 | 275,000 | 25,000 | |
May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 46.02 | 9,252 | 425,777 | 332,130 | 341.4 K to 332.1 K (-2.71 %) |
May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 45.21 | 9,638 | 435,734 | 341,382 | 351 K to 341.4 K (-2.75 %) |
May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 44.44 | 6,885 | 305,969 | 351,020 | 357.9 K to 351 K (-1.92 %) |
May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 11.00 | 25,000 | 275,000 | 357,905 | 332.9 K to 357.9 K (+7.51 %) |
May 16 2018 | ATRA | Atara Biotherapeut ... | Porter Derrell | SVP, Head of Global ... | Option Exercise | M | 14.30 | 16,334 | 233,576 | 113,666 |